Answers are grounded in this paper and cite their sources.
PURPOSE Cervical cancer is largely preventable, yet mortality persists where HPV vaccination, screening, referral, and timely treatment fail to reach populations equitably. Brazil is a middle-income country with universal health care, continental heterogeneity, and vital records capturing race/color, enabling unusually granular subnational analysis. We quantified temporal trends and intersecting geographic-racial patterns in cervical cancer mortality across all 27 federative units from 2010-2023, spanning Brazil’s 2014 national HPV vaccination rollout. METHODS We conducted a nationwide ecological study using female cervical cancer deaths from SIM/DATASUS (ICD-10 C53). Population denominators came from official IBGE population estimates. Annual and state-level crude rates were calculated per 100,000 women. Regional period age-standardized mortality rates used age-specific deaths and population denominators across 2010-2023, directly standardized to the WHO 2000 population. APC was estimated by log-linear regression. RRs and 95% CIs used Poisson approximation. Race/color was analyzed as recorded in SIM. RESULTS Brazil recorded 84,794 deaths, increasing from 4,986 in 2010 to 7,209 in 2023 (+44.6%); after accounting for female population growth, crude mortality rose from 5.01 to 6.65/100,000 (APC +2.20%/year, 95% CI +1.87 to +2.53; R 2 = 0.947). In 2023, state-level crude mortality varied 3.24-fold, from 4.66/100,000 in Minas Gerais to 15.10/100,000 in Acre. The period age-standardized North-South gradient was substantial: 13.27 versus 5.86/100,000 (RR 2.26, 95% CI, 2.21 to 2.32), corresponding to approximately 9,000 excess deaths in the North relative to the South reference. Among deaths classified as White, Brown, or Black, Brown women represented 78.1% in the North, whereas White women represented 84.5% in the South, reflecting regional racial-demographic composition. CONCLUSION Preventable cervical cancer mortality in Brazil is rising and remains geographically concentrated despite universal health care. National averages conceal substantial within-country inequities that follow regional and racial-demographic patterns. These findings support targeted strengthening of HPV vaccination, organized screening, referral, and timely treatment, and offer a data-driven model for monitoring within-country cancer inequities in middle-income settings.
No takes yet. Share an insight, caveat, or question.
Minuzzo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: